Latest Articles

Publication Date
Lower Urinary Tract Dysfunction Among Patients Undergoing Surgery for Deep Infiltrating Endometriosis: A Prospective Cohort Study.

Background/Objectives: Postsurgical lower urinary tract dysfunction (LUTD) is a common problem following deep infiltrating endometriosis (DIE) resection. The condition may be caused either by surgically induced damage to the bladder …

Published: Dec. 3, 2024, midnight
Successful Treatment of Abdominal Wall Advanced Endometriosis-Associated Clear Cell Carcinoma with AKT Pathway Inhibitor: Case Report.

The emergence of endometriosis-associated clear cell carcinoma (CCC) within the abdominal wall is a notably rare phenomenon. This condition predominantly impacts females who have previously undergone surgical interventions, including hysterectomy …

Published: Nov. 26, 2024, midnight
Morphology of mitochondrial network in disseminated endometriosis cells in spontaneous pneumothorax diagnostic process.

Circulating endometrial cells (CECs) have emerged as a new biomarker of advanced disease in women with endometriosis. The identification of several subtypes of CECs (e.g., stem cell-like, epithelial, glandular, stromal) …

Published: Nov. 24, 2024, midnight
A Case Report on Endometriosis-Associated Intestinal Tumour Following Hysterectomy: Diagnostic Challenges and Implications for Hormone Replacement Therapy (HRT) Guidelines - Cureus

A Case Report on Endometriosis-Associated Intestinal Tumour Following Hysterectomy: Diagnostic Challenges and Implications for Hormone Replacement Therapy (HRT) Guidelines Cureus

Published: Nov. 23, 2024, 3:36 p.m.
A Case Report on Endometriosis-Associated Intestinal Tumour Following Hysterectomy: Diagnostic Challenges and Implications for Hormone Replacement Therapy (HRT) Guidelines.

Endometriosis is a complex condition that is often underdiagnosed, leaving rare but serious risks such as malignant transformation overlooked in many cases. Malignant transformation, especially in extra-gynaecological sites, poses significant …

Published: Nov. 23, 2024, midnight
HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain - Scrip

HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain Scrip

Published: Nov. 18, 2024, 4:48 a.m.
HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain - Citeline News & Insights

HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain Citeline News & Insights

Published: Nov. 18, 2024, 4:48 a.m.
HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain - insights.citeline.com

HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain insights.citeline.com

Published: Nov. 18, 2024, 4:48 a.m.
HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain - Citeline

HopeMed Hopes For First-Line Inroads In Endometriosis-Associated Pain Citeline

Published: Nov. 18, 2024, 4:48 a.m.
Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain.

To compare the effects of five combined oral contraceptives (COCs) - ethinylestradiol (EE) 30 μg/dienogest (DNG) 2 mg, EE 20 μg/drospirenone (DRSP) 3 mg, 17β-estradiol (E2) 1.5 mg/nomegestrol acetate (NomAc) …

Published: Nov. 13, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!